DERIVES ANTIGENES ASSOCIES AUX TUMEURS DE LA FAMILLE MAGE, ET SEQUENCES D'ACIDES NUCLEIQUES CODANT CES DERIVES, UTILISES POUR LA PREPARAITON DE PROTEINES DE FUSION ET DE COMPOSITIONS DESTINEES A LA VACCINATION
The present invention relates to novel proteins and to their production, from the MAGE family. In particular, to a MAGE protein fused to an immunological fusion partner, such as Lipoprotein D. Such antigens may be formulated to provide vaccines for the treatment of a range of tumours. Novel methods for purifying MAGE proteins are also provided.